concept

SENESCENT MICROGLIA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SENESCENT MICROGLIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

55Connections

12Hypotheses

7Analyses

35Outgoing

20Incoming

9Experiments

15Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SENESCENT MICROGLIA
Key Genes/Proteins	INFLAMMATORY FACTORS

Pathway Diagram

graph TD
    SENESCENT_MICROGLIA["SENESCENT MICROGLIA"]
    SENESCENT_MICROGLIA -->|"co_expressed_with"| TREM2["TREM2"]
    SENESCENT_MICROGLIA -->|"expressed in"| SASP["SASP"]
    SENESCENT_MICROGLIA -->|"risk_factor_for"| Neurodegenerative_Diseases["Neurodegenerative Diseases"]
    SENESCENT_MICROGLIA -->|"contributes to"| Brain_Inflammation["Brain Inflammation"]
    SENESCENT_MICROGLIA -->|"contributes to"| Alzheimer_s_Disease["Alzheimer's Disease"]
    SENESCENT_MICROGLIA -->|"contributes to"| Inflammaging["Inflammaging"]
    SENESCENT_MICROGLIA -->|"activates"| brain_inflammation["brain inflammation"]
    SASP -->|"expressed in"| SENESCENT_MICROGLIA
    ABT_737["ABT-737"] -->|"downregulates"| SENESCENT_MICROGLIA
    TGM2["TGM2"] -->|"upregulates"| SENESCENT_MICROGLIA
    TREM2 -->|"regulates"| SENESCENT_MICROGLIA
    lactic_acid["lactic acid"] -.biomarker for.-> SENESCENT_MICROGLIA

Outgoing (35)

Target	Relation	Type	Str
SASP	associated_with	phenotype	0.95
Neuroinflammation	associated_with	phenotype	0.90
SASP	expressed_in	process	0.90
Pro-inflammatory cytokines	upregulates	pathway	0.90
Senescence-Associated Secretory Phenotype	associated_with	phenotype	0.90
SASP secretion	causes	process	0.90
AGING	promotes	process	0.90
TREM2	co_expressed_with	gene	0.90
Neurodegenerative Diseases	risk_factor_for	disease	0.90
Brain Aging	associated_with	process	0.90
Cognitive Decline	associated_with	phenotype	0.87
Brain Inflammation	contributes_to	process	0.85
Inflammaging	contributes_to	process	0.85
Alzheimer Disease	implicated_in	disease	0.85
Alzheimer's Disease	contributes_to	disease	0.85
Alzheimer'S Disease	contributes_to	disease	0.85
NEURODEGENERATION	risk_factor_for	process	0.85
PARKINSON'S DISEASE	contributes_to	disease	0.80
ALS	contributes_to	disease	0.80
ALZHEIMER'S DISEASE	contributes_to	disease	0.80
brain aging	promotes	process	0.80
Microglial Heterogeneity	contributes_to	phenotype	0.80
Alzheimer's Disease	risk_factor_for	disease	0.80
INFLAMMATORY FACTORS	secretes	protein	0.80
Alzheimer's disease	associated_with	disease	0.70
brain inflammation	activates	process	0.70
hippocampus	expressed_in	brain_region	0.70
amyotrophic lateral sclerosis	implicated_in	disease	0.70
neuroinflammation	causes	phenotype	0.70
chronic neuroinflammation	causes	phenotype	0.70
SASP	causes	process	0.70
SASP	activates	process	0.70
cognitive decline	causes	phenotype	0.70
brain inflammation	associated_with	process	0.70
MMP2/MMP9	associated_with	gene	0.50

Incoming (20)

Source	Relation	Type	Str
SASP	expressed_in	process	0.95
SASP	associated_with	process	0.95
ABT-737	downregulates	drug	0.92
TGM2	upregulates	gene	0.90
Abt-737	associated_with	drug	0.85
Amyloidosis	associated_with	disease	0.85
Aging	associated_with	process	0.85
Tauopathy	associated_with	disease	0.80
TREM2	regulates	gene	0.80
p16INK4A	biomarker_for	protein	0.70
ABT-737	inhibits	drug	0.70
TREM2	expressed_in	gene	0.70
senolytic agents	inhibits	drug	0.70
CXCL1	biomarker_for	biomarker	0.70
CXCL2	biomarker_for	biomarker	0.70
maresin analogs	activates	drug	0.70
p16	biomarker_for	gene	0.70
Lamin B1 degradation	biomarker_for	process	0.70
lactic acid	biomarker_for	protein	0.70
MMP-3	biomarker_for	biomarker	0.70

Targeting Hypotheses (12)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Senescent Microglia Resolution via Maresins-Senolytics Combi	0.791	neurodegeneration	Neuroinflammation resolution mechanisms
SASP-Secreted MMP-9 from Senescent Microglia Generates Patho	0.713	ALS	What are the mechanisms by which microgl
TREM2-Dependent Senescent Microglia Disrupt Astrocyte Commun	0.600	neurodegeneration	Gene expression changes in aging mouse b
Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senesc	0.564	neuroinflammation	What molecular mechanisms drive the tran
Severely Depleted mtDNA and Impaired OXPHOS Defines Senescen	0.520	neurodegeneration	How can senescent microglia be molecular

GATA4 Stabilization and NF-κB Co-activation Identifies Senes	0.520	neurodegeneration	How can senescent microglia be molecular
Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia f	0.520	neurodegeneration	How can senescent microglia be molecular
SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43	0.511	ALS	What are the mechanisms by which microgl
Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and	0.502	ALS	What are the mechanisms by which microgl
TREM2-Mediated Senescent Microglial Reprogramming of Astrocy	0.380	neurodegeneration	Spatial Transcriptomics Analysis of Alzh
TBK1 Loss Drives MMP-9-Mediated TDP-43 Fragmentation Through	0.376	ALS	What are the mechanisms by which microgl
SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclea	0.361	ALS	What are the mechanisms by which microgl

Mentioning Analyses (7)

Scientific analyses that reference this entity

How can senescent microglia be molecularly distinguished from beneficial activat

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.720

How do regional, age, and sex-dependent differences in microglial populations af

neuroinflammation | 2026-04-06 | 7 hypotheses Top: 0.714

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-02 | 0 hypotheses

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.782

Experiments (9)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Proposed experiment from debate on Senolytics targeting p16/p21+ senes	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis	validation	Neuroinflammation	0.400	0.50	human	proposed	$2,960,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the S [PMID:37738560]	Justice JN, Leng XI, LeBrasseur NK, Tchk	J Gerontol A Biol Sci Med Sci	2024	1
Sex differences in autophagy-mediated diseases: toward precision medicine. [PMID:32264724]	Shang D, Wang L, Klionsky DJ, Cheng H, Z	Autophagy	2021	1
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populatio [PMID:33144684]	He D, Wang D, Lu P, Yang N, Xue Z, Zhu X	Oncogene	2021	1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells [PMID:26657143]	Chang J, Wang Y, Shao L, Laberge RM, Dem	Nat Med	2016	1
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. [PMID:25754370]	Zhu Y, Tchkonia T, Pirtskhalava T, Gower	Aging Cell	2015	1
Senolytic elimination of therapy-induced senescent cells by ABT-263 improves che [PMID:41423036]	Zhang D, Zhu J, Zou R, Zhang H, Yu BP, L	Biochemical pharmacology	2026	0
Disentangling causality in brain aging: The complex interplay between glial sene [PMID:41871753]	Unknown	Exp Neurol	2026	0
Comprehensive assessment of the genomic stability of human induced pluripotent s [PMID:41877289]	Zhang K, Na T, Jia C, Yuan X, Guo M, Yan	Stem cell research & therapy	2026	0
Characterization of the Direct and Indirect Inhibition of Apoptosis by Full-Leng [PMID:41589352]	Elsner C, Epasto LM, Cieren A, Gendreizi	Chembiochem : a European journ	2026	0
Exploring the key molecular mechanisms and immune microenvironment of oxidative [PMID:41591671]	Cai Z, Li J, Li T, Peng Q	Discover oncology	2026	0
Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells. [PMID:41000837]	Unknown	bioRxiv	2025	0
Navitoclax acts synergistically with irradiation to induce apoptosis in preclini [PMID:41430412]	Vardon A, Haston S, Hamdi H, Cooksley G,	Scientific reports	2025	0
Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's [PMID:38637622]	Rachmian N, Medina S, Cherqui U, Akiva H	Nat Neurosci	2024	0
Combination of senolytic and pro-resolving mediator shows synergistic benefit in [PMID:synthetic_19]	Unknown	Nat Aging	2024	0
Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's [PMID:38637622]	Rachmian N, Medina S, Cherqui U, Akiva H	Nature neuroscience	2024	0
Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's [PMID:38637622]	Unknown	Nature neuroscience	2024	0
Senolytic treatment diminishes microglia and decreases severity of experimental [PMID:39487537]	Drake SS, Zaman A, Gianfelice C, Hua EM,	Journal of neuroinflammation	2024	0
CSF markers of microglial senescence predict cognitive decline in Alzheimer's di [PMID:synthetic_20]	Unknown	Ann Neurol	2023	0
Senescent microglia accumulate in Alzheimer's disease brains and drive neuroinfl [PMID:synthetic_16]	Unknown	Nature	2023	0
Maresin 1 reprograms microglia from pro-inflammatory to phagocytic phenotype via [PMID:synthetic_17]	Unknown	Cell	2022	0

Debates (15)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP-Mediated Complement Cascade Amplification

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

While single-cell sequencing reveals microglial heterogeneity across regions, ag

closed · Rounds: 4 · Score: 0.73 · 2026-04-22

The debate revealed that microglial senescence markers are poorly defined compar

closed · Rounds: 4 · Score: 0.72 · 2026-04-22

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

Related Research

Hypotheses and analyses mentioning SENESCENT MICROGLIA in their description or question text

GATA4 Stabilization and NF-κB Co-activation Identifies Senescent Microglia

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview GATA4 Stabilization and NF-κB Co-activation Identifies Senescent Microglia starts from the claim

Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia from Inflammatory Act

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia from Inflammatory Activation starts f

SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 Nuclear Retention L

Score: 0.511 · ALS · 2026-04-27

The hypothesis proposes that MMP-9 (matrix metalloproteinase-9), secreted via the senescence-associated secretory phenot

Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and Partial Compensators

Score: 0.502 · ALS · 2026-04-26

CHI3L1 (YKL-40), CHIT1 (chitotriosidase), and CHI3L2 are among the most consistently elevated proteins in ALS biofluids

TREM2-Mediated Senescent Microglial Reprogramming of Astrocyte Networks

Score: 0.380 · neurodegeneration · 2026-04-27

This hypothesis proposes that age-related TREM2 signaling dysfunction drives microglia into a senescent state that funda

TBK1 Loss Drives MMP-9-Mediated TDP-43 Fragmentation Through Senescent Microglia

Score: 0.376 · ALS · 2026-04-26

TBK1 deficiency in microglia creates a pathological cascade that directly generates ALS-driving TDP-43 pathology through

SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclear-Cytoplasmic Transp

Score: 0.361 · ALS · 2026-04-26

This hypothesis proposes that MMP-9 secreted by senescent microglia in the SASP drives ALS pathology through disruption

SENESCENT MICROGLIA

Understanding Entity Pages

Pathway Diagram

Outgoing (35)

Incoming (20)

Targeting Hypotheses (12)

Mentioning Analyses (7)

How can senescent microglia be molecularly distinguished from beneficial activat

How do regional, age, and sex-dependent differences in microglial populations af

Senescent cell clearance as neurodegeneration therapy

Senescent cell clearance as neurodegeneration therapy

Senolytic therapy for age-related neurodegeneration

Senolytic therapy for age-related neurodegeneration

Neuroinflammation resolution mechanisms and pro-resolving mediators

Experiments (9)

Related Papers (20)

Debates (15)

Extended debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: SASP-Mediated Complement Cascade Amplification

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

While single-cell sequencing reveals microglial heterogeneity across regions, ag

The debate revealed that microglial senescence markers are poorly defined compar

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

Related Research

GATA4 Stabilization and NF-κB Co-activation Identifies Senescent Microglia

Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia from Inflammatory Act

SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 Nuclear Retention L

Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and Partial Compensators

TREM2-Mediated Senescent Microglial Reprogramming of Astrocyte Networks

TBK1 Loss Drives MMP-9-Mediated TDP-43 Fragmentation Through Senescent Microglia

SASP-Secreted MMP-9 from Senescent Microglia Disrupts Nuclear-Cytoplasmic Transp